The Manila Times

AlphaTON’s Cyncado Therapeutics and Australia’s ADDRI to Launch Investigator-Initiated ...

ADDRI-sponsored trial in Australia planned to enroll approximately 50 patients, led by A/Prof Steven Kao and Dr Melvin Chin; part of Cyncado’s international program for mesothelioma ...